by rss feed | May 25, 2025 | CRISPR therapy, Editas, News Feeds, Verve Therapeutics, weekly reads
There has been a sizable downturn for the CRISPR therapy biotech arena. Firms like Editas, Verve, Intellia, and even CRISPR Therapeutics, which has garnered an FDA approval, have had struggles recently. It feels like a disconnect here in a way because overall gene...
by rss feed | Nov 22, 2022 | CRISPR, CRISPR sickle cell, CRISPR therapy, gene editing, Informational, News Feeds
When I first heard of CRISPR gene editing I was excited for my lab to try it out, but it seemed a long way from the field having even one CRISPR therapy available to treat human disease. In the Knoepfler lab, we study genetic and genomic programming in human...
